The Vasculitis Syndromes

Similar documents
PAEDIATRIC VASCULITIS

Vasculitis local: systemic

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis

VASCULITIS. Case Presentation. Case Presentation

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

Vasculitis local: systemic

Atlas of the Vasculitic Syndromes

VASCULITIC SYNDROMES. Howard L. Feinberg, D.O., F.A.C.O.I., F.A.C.R. OPSC 2018

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi

SHO Teaching. Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth

Overview. = inflammation of vessel wall. Symptoms and signs depend on the tissue of which the vessels are affected

Annual Rheumatology & Therapeutics Review for Organizations & Societies

Done by: Shatha Khtoum

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward

December 6, 2010 Asthma and Rheumatic Disorders and Vasculitis

Vasculitides in Surgical Neuropathology Practice

A. Smržová. III. Interní klinika FN Olomouc nefrologická, revmatologická a endokrinologická

RARE JUVENILE PRIMARY SYSTEMIC VASCULITIS

GRANULOMATOSIS WITH POLYANGIITIS

VASCULITIS AND VASCULOPATHY

Index. Note: Page numbers of article titles are in boldface type.

Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura)

vasculitis Patomorfologia vasculitis (arteritis) caused by infections vasculitis (arteritis) caused by infections

Vasculitis. Seth Mark Berney, MD Professor of Medicine Chief, Division of Rheumatology University of Arkansas for Medical Sciences

Small Vessel Vasculitis

The role of pathology in the diagnosis of systemic vasculitis

ST - segment Elevation Myocardial Infarction complicating an atypical Kawasaki disease

Vasculitis Prof. Dr. med. Katharina Glatz Pathologie

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

Small Vessel Vasculitis

Systemic Sclerosis. Scleroderma

Management of Acute Vasculitis. CMT teaching 3 rd June 2015 Caroline Wroe

*HSP is a common vasculitis of small vessels with cutaneous & systemic complications. Its etiology is unknown& often follows URTIs.

A number of factors point to the likelihood of a person with RA developing RV:

CHECK LIST FORM-SCREENING

Diagnostic Procedures for Vasculitis

TAKAYASU S ARTERITIS. Second-stage symptoms include:

CENTRAL NERVOUS SYSTEM VASCULITIS

CHECK LIST FORM-SCREENING

Scleritis LEN V KOH OD

Rituximab treatment for ANCA-associated vasculitis in childhood

A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature

Cardiovascular Pathology

Glomerular pathology in systemic disease

CHECK LIST FORM-MONTH 27 (Please note Month 27 is from enrolment not randomisation)

VASCULITIS ACOI Robert L. DiGiovanni, DO, FACOI

ANCA associated vasculitis in China

KAWASAKI DISEASE. What is Kawasaki disease? Causes

EDITORIAL. Issue Seventeen, October Editorial Team. Issue Seventeen. Info link

29 Glomerular disease: an overview

Year 2004 Paper one: Questions supplied by Megan

AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS

Crescentic Glomerulonephritis (RPGN)

ARTHRITIS FOUNDATION VASCULITIS

RATIONALE. K Without therapy, ANCA vasculitis with GN is associated. K There is high-quality evidence for treatment with

Vasculitis. Marwan Adwan. 4 th year MBBS. Consultant Rheumatologist. MBChB, MRCPI, MSc, MRCP (rheum)

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

Takayasu s Arteritis: A Case Report With Global Arterial Involvement

Case Presentation. By Eman El Sharkawy Ass. Professor of cardiology Alexandria University

CUTANEOUS VASCULITIS. Katharine Warburton ST6 Dermatology

FAQ Identifying and enrolling participants

Update on nomenclature and classification of vasculitis

Functional vascular disorders

Rheumatology Primer: What Labs and When

Vasculitis Update. A selective review of what s new. Dr Jonathan Akikusa MBBS FRACP

9/11/11. Temporal Arteritis. Background. Background. Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service

17 : 3. Renu Saigal, Amit Kansal, Jaipur ABSTRACT:

Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis

Cerebrovascular Disease

Autoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens:

VCRC-OMERACT ANCA-Vasculitis Outcome Measure Initiative Comparative Outcome Measure Exercise-Training Cases

Autoimmunity. Autoimmune Disease

Review Article. Current concepts in Anti-Neutrophil Cytoplasmic Antibody (ANCA) associated Vasculitis. Milind Aurangabadkar

Granulomatosis with Polyangiitis (Wegener s)

Neuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow

The systemic vasculitides were traditionally classified. Treatment of ANCA-associated Systemic Vasculitis. H. Michael Belmont, M.D.

Guideline on the clinical management of Henoch Schonlein Purpura (HSP)

SMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018

Blood and Circulation Module Year 3 Semester 1

DIABETES MELLITUS. Kidney in systemic diseases. Slower the progression: Pathology: Patients with diabetes mellitus are prone to other renal diseases:

Histopathology: Glomerulonephritis and other renal pathology

HYPERTENSIVE VASCULAR DISEASE

Shawkat Michel, M.D.

ANCA-associated systemic vasculitis (AASV)

Lung diseases of Vascular Origin. By: Shefaa Qa qqa

EULAR/ERA-EDTA recommendations for the management of ANCAassociated

RAPIDLY FAILING KIDNEYS. Dr Paul Johny 2 nd yr DNB Medicine Resident

CASE 4 A RARE CASE OF INTRALUMINAL GLOMERULAR CAPILLARY DEPOSITS

HEMORRHAGIC BULLOUS HENOCH- SCHONLEIN PURPURA: A CASE REPORT

Tell me more about vasculitis. Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital

Kawasaki Disease. 1:45 2:30 p.m. James Nocton, MD Benjamin Goot, MD. Children s Specialty Group. All rights reserved.

Clinical characteristics and outcome of vasculitides

NON-ATHEROSCLEROTIC PATHOLOGY OF THE CAROTID ARTERIES

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT

Prepared by Sarah Bozeman, MD, University of Mississippi Healthcare, and John Seyerle, Ohio State University

Content. Polyarteritis nodosa. Vasculitis. Giant cell arteritis. Primary cerebral angiitis. Other autoimmune CNS disease.

UNFOLDING NATURE S ORIGAMI: MEDICAL TREATMENT OF TAKAYASU ARTERITIS AND GIANT CELL ARTERITIS

Pharmacy Management Drug Policy

Plan. Sarcoidosis 21/07/2017. Sarcoidosis Liver involvement. Sarcoidosis GI involvement. Sarcoidosis Diagnosis

Transcription:

The Vasculitis Syndromes

Definition Inflammation and damage of blood vessels Single organ skin Several organ systems Primary Secondary Heterogeneity Overlap

Primary Vasculitis Syndromes Wegener s granulomatosis Churg-Strauss syndrome Polyarteritis nodosa Microscopic polyangitis Giant cell arteritis Takayasu s arteritis Henoch-Schönlein purpura Idiopthic cutaneous vasculitis Essential mixed cryoglobulinemia Behcet s syndrome Isolated vasculitis of the CNS Cogan s syndrome Kawasaki disease

Secondary Vasculitis Syndromes Drug-induced vasculitis Serum sickness Vasculitis associted with other primary diseases, infection, malignancy, rheumatic disease

Pathophysiology and Pathogenesis Immunpathogenic mechanisms Pathogenic immune complex formation and/or deposition:hepatitis B PAN, Hepatitis C Essential mixed cryoglob. Production of antineutrophilic cytoplasmic antibodies: Wegener s, Churg-Strauss, Microsc. polyang. Pathogenic T lymphocyte responses and granuloma formation:giant cell, Takayasu s, Wegener, Churg-Strauss

Approach to the patient: Vasculitis Unexplained systemic illness Angiogram of organs Definitive diagnosis biopsy of involved tissue

Wegener s granulomatosis

Incidence and Prevalence Prevalence: 3 per 100.000 Age of onset: 40 years Primary vasculitis syndrome damage of vessels Immunopathogenic mechanisms ANCA= antineutrophil cytoplasmic antibody c-anca= cytoplasmic ANCA (diffuse, granular cytoplasmic staining by immunofluorescence microscopy) Detectable antibodies to proteinase-3 Granuloma formation

Pathology and pathogenesis Necrotizing vasculitis of small arteries and veins + granuloma formation Lung: multiple, bilateral, nodular cavitary infiltrates Biopsy: necrotizing granulomatous vasculitis Upper airway lasions: sinuses, nasopharynx Kidney: rapidly progressive crescentic

Clinical manifestations Upper airways 95% Purulent or bloody nasal discharge Nasal septal perforation Saddle nose deformity Serous oitis media, hearing loss Subglottic tracheal stenosis severe airway obstruction Pulmonary involvement:hemoptysis, dyspnea 85-90% Eye: scleritis, conjunctivitis, retroorbital mass laesion Skin: palpable purpura, papules, vesicles, subcutaneous nodules Heart: pericarditis, coronary vasculitis CNS: mononeuritis multiplex, cerebral vasculitis Kidney disease: 77%, proteinuria, hematuria, red blood cell casts, rapidly progressive renal failure

Laboratory findings ESR Mild anemia, leukocytosis, thrombocytosis 90% positive antiproteinase-3 c-anca

Diagnosis of WG Tissue biopsy: necrotizing granulomatous vasculitis c-anca positivity

Treatment of WG Cyclophosphamide induction for severe disease: 2 mg/kg per day orally + steroids Cyclophosphamide for 1 year following the induction of complete remission Prednisone 1 mg/kg per day Improvement: 90% Complete remissions: 75% Later relapses Remission maintenance: Azathioprine, Methotrexate 2 years past remission

Treatment of WG 2 Mycophenolate mofetil 1000 mg twice a day Rituximab (anti-cd20) Trimethoprim-sulfamethoxazole

Churg-Strauss syndrome

Definition Allergic angiitis and granulomatosis Asthma, peripheral and tissue eosinophilia, extravascular granuloma formation, vasculitis of multiple organs

Incidence and Prevalence 1-3 cases per million Onset: 48 years

Pathology and Pathogenesis Necrotizing vasculitis Small and medium-sized muscular erteries, capillaries, veins, and venules Granuloma formation Infiltration of the tissues with eosinophils Lung, skin, heart, kidney. Peripheralnervous system, GI

Clinical and Laboratory Manifesttions Asthma, pulmonary infiltrates Mononeuritis multiplex Allergic rhinitis and sinusitis Skin lesions: purpura, subcutaneous nodules Eosinophilia ESR p-anca = perinuclear ANCA (antimyeloperoxidase)

Diagnosis Asthma Peripheral blood eosinophilia Biopsy

Treatment Steroids Cyclophosphamide Survival rate:72%

Polyarteritis nodosa

Definition Multisystem, necrotizing vasculitis Small and medium-sized muscular arteries Renal and visceral arteries

Incidence and Prevalence Very uncommon disease

Pathology and Pathogenesis Segmental lesions Bifurcations and branching of arteries Aneurysmal dilatations up to 1 cm in size Kidney: arteritis without glomerulonephritis Hepatitis B antigenemia: 10-30% Circulating immune complexes composed of hepatitis B antigen

Clinical manifestations Fever, weight loss Kidney renal failure, hypertension Joint arthritis, arthralgia, myalgia Peripheral neuropathy, mononeuritis multiplex GI abdominal pain, bleeding, bowel infarction and perforation, liver infarction, pancreatic infarction Skin purpra, nodules, cutaneous infarcts, livedo reticularis Heart congestive heart failure, myocardial infarction, pericardiis Testicular and ovarian pain CNS cerebral vascular accident, seizure, altered mental status

Laboratory tests Leukocyte count ESR Anemia of chronic disease Hypergammaglobulinemia HBsAg pozitivity 30%

Diagnosis Vasculitis on biopsy material of involved organs Angiography aneurysms of small and medium-sized arteries

Treatment Steroid Cyclophosphamide PAN + Hepatitis B virus pozitivity: Antiviral drugs+ steroid+plasma exchange

Microscopic polyangitis Glomerulonephritis renal failure Pulmonary capillaritis hemoptysis Mononeuritis multiplex GI vasculitis Cutaneous vasculitis Age of onset: 57 years panca positivity 75%

Diagnosis and Treatment Kidney,lung: histologic evidence of vasculitis Steroid +Cyclophosphamide

Giant cell arteritis and Polymyalgia rheumatica

Definition Temporal arteritis or Cranial arteritis Inflammationof medium- and large-sized arteries Temporal artery Aorta and its main branches Polymyalgia rheumatica: pain in the muscles of the neck, shouldersm lower back >50 years

Clinical and Laboratory Manifestations Fever,anemia ESR Headache Temporal artery tender, thickened, nodular Ischemic optic neuropathy visual loss blindness Increased risk of aortic aneurysm dissection

Diagnosis Biopsy of the temporal artery Giant cell arteritis

Treatment Steroid: Prednisone40-60 mg/day 1 month Treatment for 2 years ESR Polymyalgia rheumatica: Prednisone 10-20 mg/day ESR

Takayasu s arteritis Inflammatory and stenotic disease of medium- and large-sized arteries Aortic arch and its branches =Aortic arch syndrome Incidence: 1-2 cases/million/year Angiography

Frequency of angiographic abnormalities Subclavian: 93% Common carotid: 58% Abdominal aorta: 47% Aortic arch: 35% Vertebral: 35% Pulmonary: 10-40% Coronary < 10%

Clinical manifestetions Panarteritis with inflammatory mononuclear cell infiltrates Narrowing of the lumen Pulses absent ESR, anemia, gammaglobulin

Diagnosis Young woman Decrease or absence ofperipheral pulses Discrepancies in blood pressure Arterial bruits Arteriography irregular vessel walls, stenosis, poststenotic dilatation, aneurysm formation, occlusion, evidence of increased collateral circulation

Treatment Steroid: prednisone 40-60 mg/day Methotrexate 25 mg/week Surgical correction of stenosed arteries

Henoch-Schönlein purpura Anaphylactoid purpura Palpable purpura over the buttocks and lower extremities Arthralgias GI signs colicky abdominal pain, melena/hematochesia Glomerulonephritis proteinuria, microscopic hematuria, red blood cell casts Small-vessel vasculitis Children 4-7 years Immune-complex deposition Serum IgA

Diagnosis Clinical symptoms Skin biopsy leukocytoclastic vasculitis

Treatment Do not require therapy Steroids: Prednisone 1 mg/kg/day

Idiopathic cutaneous vasculitis =Hypersensitivity vasculitis =Cutaneous leukocytoclastic vasculitis Dermis, small vessels Only skin involvement palpable purpura, chronic urticaria Diagnosis: biopsy vasculitis Etiology: drug, infection, underlying disease Treatment:microbe antimicrobal therapy, steroids

Essential mixed cryoglobulinemia Cryoglobulins: cold-precipitable monoclonal or polyclonal immunoglobulins Cutaneous vasculitis, palpable purpura, arthralgias, glomerulonephritis Hepatitis C infection Treatment:IFN-α, Ribavirin

Behcet s syndrome Recurrent, painful aphthous oral ulcerations in the oral cacity Recurrent genital ulcers Iritis Cutaneous lesions Treatment: topical steroids, Prednisone

Isolated vasculitis of the CNS Severe headache, focal neurologic defects Abnormal MRI of the brain Abnormal liquor Abnormal cerebral angiogram vasculitis Brain biopsy Treatment:Prednisone+Cyclophosphamid e

Kawasaki disease =Mucocutaneous lymph node syndrome Nonsuppurative cervical adenitis Children > 2 years Coronary artery aneurysms 25% Treatment:IVIG+ Aspirin

Raynaud s Phenomenon Episodic vasoconstriction inthe fingers and toes Tip of the nose and earlobes Cold exposure pallor cyanosis erythema rewarming of the fingers, vasoconstriction ischemia reperfusion Normal population: 3-5%, women Primary and/or secondary Nailbed cutaneous capillaries viewed stereoscopic microscope

Treatment Dress warmly, calcium channel blockers, ARBs (angiotensin II receptor blockers) Losartan, iv. prostaglandins, low-dose aspirin